tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum

Craig-Hallum initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy rating and $12 price target

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1